Breaking News
15 hours ago
Pharma Now Editorial Team

Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Roche's divarasib beats sotorasib and adagrasib on PFS and OS in phase III Krascendo 1, triggering imminent FDA and EMA submissions.
Pharma Now Editorial Team

Novartis secures EC approval for Itvisma in SMA patients aged two and older, the first gene replacement therapy cleared for this broad EU population.
Pharma Now Editorial Team

Morepen Laboratories activates commercial supply under an Rs. 825 crore CDMO contract, marking a shift from agreement to GMP-compliant production.
Pharma Now Editorial Team

Mankind Pharma partners with Denovo Sciences to embed AI into early drug discovery, targeting shorter timelines and stronger lead candidates.
Pharma Now Editorial Team
